| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 15, 2026 | Option exercise(M) | 231 | — | — | 9K |
| Feb 15, 2026 | Sell(S) | 75 | $8.47 | $635 | 9K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 15, 2026 | Option exercise(M) | 98 | — | $0 | 780 |
| Feb 15, 2026 | Option exercise(M) | 133 | — | $0 | 531 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-057157) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Seres Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001193125-26-057157"
Use Arkolith to summarize insider buying and selling at Seres Therapeutics, Inc. over the last 90 days and cite the filings.